Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

FLT4 Protein (Dimer, glycosylated, Soluble) (Fc Tag)

FLT4 Origine: Humain Hôte: Cellules d'insectes Recombinant > 90 % by SDS-PAGE Active
N° du produit ABIN1589551
  • Antigène Voir toutes FLT4 Protéines
    FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Attributs du protein
    glycosylated, Dimer, Soluble
    Origine
    • 17
    • 5
    • 3
    • 2
    Humain
    Source
    • 15
    • 6
    • 2
    • 2
    • 1
    • 1
    Cellules d'insectes
    Purification/Conjugué
    Cette FLT4 protéine est marqué à la Fc Tag.
    Fonction
    VEGFR-3/FLT-4/Fc Chimera, soluble
    Séquence
    YSMTPPTLNI TEDSYVIDTG DSLSISCRGQ HPLEWTWPGA QEVLTTGGKD SEDTRVVHDC EGTEARPYCK VLLLAQTHAN NTGSYHCYYK YIKARIEGTT AASTYVFVRD FKHPFINKPD TLLVNRKDSM WVPCLVSIPG LNITLRSQSS ALHPDGQEVL WDDRRGMRVP TQLLRDALYL QCETTWGDQN FLSNLFVVHI TGNELYDIQL YPKKSMELLV GEKLVLNCTV WAEFDSGVTF DWDYPGKQAE RAKWVPERRS QQTHTELSSI LTIHNVSQND LGPYVCEANN GIQRFRESTE VIVHEKPFIS VEWLKGPVLE ATAGDELVKL PVKLAAYPPP EFQWYKDRKA VTGRHNPHAL VLKEVTEASA GVYTLALWNS AAGLRQNISL ELVVNVPPHI HEKEASSPSI YSRHSRQTLT CTAYGVPQPL SVQWHWRPWT PCKTFAQRSL RRRQQRDGMP QCRDWKEVTT QDAVNPIESL DSWTEFVEGK NKTVSKLVIQ DANVSAMYKC VVVNKVGQDE RLIYFYVTTI PDGFSIESEP SEDPLEGQSV RLSCRADNYT YEHLRWYRLN LSTLHDAQGN PLLLDCKNVH LFATPLEANL EEAEPGARHA TLSLNIPRVA PEDEGDYVCE VQDRRSQDKH CHKKYLSVQA LEAPRLTQNL TDLLVNVSDS LEMRCPVAGA HVPSIVWYKD ERLLEKESGI DLADSNQRLS IQRVREEDAG RYLCSVCNAK GCVNSSASVA VEGSEDKGSM ESDKTHTCPP CPAPELLGGP SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSREEM TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPML DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
    Specificité
    Chromosomal location:5q35.3
    Attributs du produit
    Length (aa):979
    Pureté
    > 90 % by SDS-PAGE
    Top Product
    Discover our top product FLT4 Protéine
  • Indications d'application
    Measured by its ability to bind recombinant rat VEGF-C in a functional solid phase binding assay. Immobilised recombinant human sVEGFR-3/Fc at 5 μg/mL can bind recombinant rat VEGF-C in a linear range of 8-500 ng/mL.
    Commentaires

    Soluble Receptors

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    The lyophilized sVEGFR-3/Fc is soluble in water and most aqueous buffers and should be reconstituted in PBS or medium to a concentration not lower than 100 μg/mL.
    Buffer
    PBS
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Lyophilized samples are stable for greater than six months at -20°C to -70°C. Reconstituted sVEGFR-3/Fc should be stored in working aliquots at -20°C. Avoid repeated freeze-thaw cycles!
    Date de péremption
    6 months
  • Antigène
    FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
    Autre désignation
    VEGFR-3/FLT-4 (FLT4 Produits)
    Synonymes
    FLT41 Protein, LMPH1A Protein, PCL Protein, VEGFR3 Protein, AI323512 Protein, Chy Protein, Flt-4 Protein, VEGFR-3 Protein, Vegfr3 Protein, cb1059 Protein, fms related tyrosine kinase 4 Protein, FMS-like tyrosine kinase 4 Protein, fms-related tyrosine kinase 4 Protein, FLT4 Protein, Flt4 Protein, flt4 Protein
    Sujet
    Recombinant human soluble Vascular Endothelial Growth Factor Receptor-3 (sVEGFR-3) was fused with the Fc part of human IgG1. The recombinant mature sVEGFR-3/Fc is a disulfide-linked homodimeric protein. The sVEGFR-3/Fc monomers have a mass of approximately 130 kDa. The soluble receptor protein consists of all 7 extracellular domains (Met1-Glu774). All three VEGF receptors belong to the class III subfamily of receptor tyrosine kinases (RTKs) characterised by the seven immunoglobulin-like loops in the extracellular domain. The expression of VEGFR-1 to -3 is almost exclusively restricted to hematopoietic precursor cells, vascular and lymphatic endothelial cells and to the monocyte/macrophage lineage. They play key roles in vasculogenesis, hematopoiesis, angiogenesis and lymphangiogenesis. The VEGFR-3/FLT-4 cDNA encodes a 1298 amino acid (aa) residue precursor protein with a 23aa residue signal peptide. Mature VEGFR-3/FLT-4 is composed of a 751aa residue extracellular domain, a 22aa transmembrane domain and a 482aa residue cytoplasmic domain. Both VEGF family members VEGF-C and VEGF-D have been shown to bind and activate VEGFR-3/FLT-4. The FLT-4 gene is widely expressed in the early embryo but becomes restricted to the lymphatic endothelial at latter stages of development. It is important for lymphangiogenesis.
    Synonyms: soluble vascular endothelial growth factor receptor-3, FLT4, PCL, LMPH1A, fms-related tyrosine kinase 4
    Poids moléculaire
    ~ 130.0 kDa
    ID gène
    2324
    NCBI Accession
    NM_002020, NP_002011
    UniProt
    P35916
    Pathways
    Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Vous êtes ici:
Support technique